Publications by authors named "Marilu Fanelli"

Claim this Profile
C
Cisplatin Resistance in Osteosarcoma: Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments.
Marilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, Serena Vella, Amira Fernandez-Ramos

Front Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.
Ilaria Buondonno, Elena Gazzano, Elisa Tavanti, Konstantin Chegaev, Joanna Kopecka, Marilù Fanelli

Cell Mol Life Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells.
Serena Vella, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Rogier Versteeg

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?
Claudia M Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Chiara Riganti

Future Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma.
Claudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, Serena Vella, Piero Picci

Expert Opin Drug Metab Toxicol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.
Claudia M Hattinger, Serena Vella, Elisa Tavanti, Marilù Fanelli, Piero Picci

Pharmacogenomics· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci

Curr Cancer Drug Targets· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito, Joanna Kopecka, Marilù Fanelli

Mol Cancer Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Claudia M Hattinger, Paola Biason, Erika Iacoboni, Sara Gagno, Marilù Fanelli

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
Konstantin Chegaev, Barbara Rolando, Daniela Cortese, Elena Gazzano, Ilaria Buondonno, Marilù Fanelli

J Med Chem· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in emerging drugs for osteosarcoma.
Claudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Stefano Ferrari

Expert Opin Emerg Drugs· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
Valeria Sero, Elisa Tavanti, Serena Vella, Claudia Maria Hattinger, Marilù Fanelli

Invest New Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
Michela Pasello, Maria Cristina Manara, Francesca Michelacci, Marilù Fanelli, Claudia Maria Hattinger

Anal Cell Pathol (Amst)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Claudia M Hattinger, Giuseppina Stoico, Francesca Michelacci, Michela Pasello, Isabella Scionti, Marilù Fanelli

Genes Chromosomes Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis